C12N 9/0065
Acting on hydrogen peroxide as acceptor
Official title: {acting on hydrogen peroxide as acceptor (1.11)}
C12N9/0065 (Acting on hydrogen peroxide as acceptor) appears on 549 US grants and 572 published applications in this corpus.
Search patents in C12N- Granted patents
- 549
- Published applications
- 572
- Assignees
- 430
- Inventors
- 1,621
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 3 | 0 |
| 1981 | 5 | 0 |
| 1982 | 4 | 0 |
| 1983 | 2 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 7 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 10 | 0 |
| 1993 | 10 | 0 |
| 1994 | 10 | 0 |
| 1995 | 9 | 0 |
| 1996 | 14 | 0 |
| 1997 | 27 | 0 |
| 1998 | 31 | 0 |
| 1999 | 39 | 0 |
| 2000 | 18 | 0 |
| 2001 | 20 | 2 |
| 2002 | 14 | 21 |
| 2003 | 22 | 25 |
| 2004 | 6 | 21 |
| 2005 | 3 | 11 |
| 2006 | 18 | 13 |
| 2007 | 8 | 5 |
| 2008 | 11 | 8 |
| 2009 | 3 | 14 |
| 2010 | 8 | 14 |
| 2011 | 7 | 11 |
| 2012 | 6 | 11 |
| 2013 | 4 | 18 |
| 2014 | 14 | 25 |
| 2015 | 9 | 42 |
| 2016 | 29 | 31 |
| 2017 | 19 | 26 |
| 2018 | 19 | 22 |
| 2019 | 14 | 36 |
| 2020 | 15 | 20 |
| 2021 | 10 | 28 |
| 2022 | 16 | 26 |
| 2023 | 17 | 36 |
| 2024 | 23 | 42 |
| 2025 | 24 | 35 |
| 2026 | 5 | 29 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and systems to secrete lignin-modifying enzymes and uses thereof11 Aug 2026US 12,703,877 B2The Board of Trustees of the Leland Stanford Junior University
- Curable composition9 Jun 2026US 12,649,842 B2BYK-Chemie GmbH
- Peroxidase activity towards 10-acetyl-3,7-dihydroxyphenoxazine3 Feb 2026US 12,540,314 B2Codexis, Inc.
- Method for preparing L-glufosinate ammonium by biological enzymatic de-racemization, glufosinate ammonium dehydrogenase mutant and use thereof13 Jan 2026US 12,522,852 B2Zhejiang University of Technology
- Composition comprising catalase, preparation method and use thereof and method for killing tumor cells6 Jan 2026US 12,514,936 B2Beijing Pharbers Genesis Pharm-Tech Co., Ltd.
- Recombinant expression vector for catalase secretion and escherichia coli strain transformed therewith8 Oct 2026US 2026/0308603 A1The Industry & Academic Cooperation in Chungnam National University (IAC)
- Plants comprising bromoform production genes8 Oct 2026US 2026/0308605 A1Imi Tami Institute for Research and Development Ltd.
- Puffed grain fermented enzyme having superoxide dismutase activity and catalase activity, production method therefor, and food composition comprising same1 Oct 2026US 2026/0293943 A1EcoMarine, LLC
- Protein/oligonucleotide core-shell nanoparticle therapeutics27 Aug 2026US 2026/0248737 A1Northwestern University
- Recombinant heme thiolate oxygenases27 Aug 2026US 2026/0250645 A1Bisy GmbH
Most cited
By later US patents
- In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny316US 5,750,376 ANeurospheres Holdings Ltd. · 1998
- In vitro growth and proliferation of multipotent neural stem cells and their progeny265US 5,851,832 ANeurospheres, Ltd. · 1998
- Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof199US 5,350,674 ABecton, Dickinson and Company · 1994
- Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins194US 5,977,307 AAlkermes, Inc. · 1999
- Fusion protein comprising tat-derived transport moiety177US 5,674,980 A1997